Back to results
US 8,075,894 B2Granted
Use of soluble CD164 in inflammatory and/or autoimmune disorders
AssigneeMerck Serono SA
InventorYolande Chvatchko
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel therapeutic uses of soluble proteins comprising the extracellular region of human CD164, in particular for treating inflammatory and/or autoimmune disorders.
Claims13
A method of reducing serum transaminase, IFN-γ and IL-6 levels in an individual having fulminant liver hepatitis comprising the administration of a composition comprising a soluble protein comprising SEQ ID NO:
- 1 to an individual having fulminant liver hepatitis in an amount sufficient to reduce serum transaminase, IFN-γ and IL-6 levels in said individual.
Dependencies are inferred from the claim text.